FIELD: medicine.
SUBSTANCE: cognitive endogenous responses in the frontal central brain to audio stimulation are recorded. Two types of tone flips of the intensity of 50 to 100 dB - essential and non-essential ones with the frequency of 1,000 Hz are supplied. Besides, a person being tested performs a speaking test in the form of counting the essential tone flips aloud. A latency and amplitude of the first, second and third negative peaks, as well as of the first, second and third positive peaks are recorded in both hemispheres. That is followed by processing the derived data at the analysis stage of 750-1,000 ms. An interhemispheric latency of a perception complex
EFFECT: method provides more reliable diagnosis that is ensured by studying the cognitive induced potentials and mathematical analysis of the derived data.
2 cl, 5 dwg, 7 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR FUNCTIONAL HEMISPHERIC ASYMMETRY | 2013 |
|
RU2528658C1 |
METHOD FOR DETERMINING HUMAN WORKING MEMORY VOLUME | 2015 |
|
RU2594152C1 |
METHOD FOR EPILEPSIA DIAGNOSTICS BASED ON COMPLEX OF PHYSIOLOGICAL INDICATORS BY METHOD OF LOGIT-REGRESSION ANALYSIS | 2016 |
|
RU2637298C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF DEMENTIA TYPE | 2002 |
|
RU2228708C1 |
METHOD OF EARLY DIAGNOSTICS OF STAGES OF COGNITIVE IMPAIRMENT IN WORKERS ENGAGED IN SERVICING AGRICULTURAL MACHINERY | 2023 |
|
RU2811312C1 |
METHOD FOR DETERMINING UREMIC ENCEPHALOPATHY DEVELOPMENT DEGREE IN PATIENTS SUFFERING FROM CHRONIC RENAL INSUFFICIENCY | 2004 |
|
RU2272562C1 |
METHOD OF DETERMINING PECULIARITIES OF EPILEPSIA COURSE BASING ON PHYSIOLOGICAL INDICATORS BY METHOD OF LOGIT-REGRESSION ANALYSIS | 2016 |
|
RU2637297C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ACUTE PERIOD OF HEMORRHAGIC PARENCHYMAL INSULT OF SUPRATENTORIAL LOCALIZATION | 2020 |
|
RU2738811C1 |
TREATING COGNITIVE DISORDERS WITH (R)-7-CHLOR-N-(QUINUCLIDIN-3-YL) BENZO[b] THIOPHEN-2-CARBOXAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 2009 |
|
RU2532327C2 |
TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2014 |
|
RU2662560C2 |
Authors
Dates
2014-06-27—Published
2013-03-22—Filed